Bionano Genomics Inc

Company Snapshot
9540 Towne Centre Drive
San Diego, CA 92121
United States
Sector: Healthcare
Industry: Medical Instruments & Supplies
Full Time Employees: 405
https://bionano.com
Please select from the dropdown
Company Financials

2020
2021
2022
Gross Profit
$2,772,847
$3,874,000
$5,945,000
Operating Income
($38,551,322)
($77,101,000)
($131,698,000)
Net Income
($41,106,351)
($72,435,000)
($132,596,000)
2020
Gross Profit
$2,772,847
Operating Income
($38,551,322)
Net Income
($41,106,351)
2021
Gross Profit
$3,874,000
Operating Income
($77,101,000)
Net Income
($72,435,000)
2022
Gross Profit
$5,945,000
Operating Income
($131,698,000)
Net Income
($132,596,000)
The above data on Bionano Genomics Inc came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
R. Holmlin
President, Chief Executive Officer and Director
$821,892
$1,932,000
$12,680
$2,766,572
R. Holmlin
$2,766,572
President, Chief Executive Officer and Director
Mark Oldakowski
Chief Operating Officer
$591,144
$897,000
$12,680
$1,500,824
Mark Oldakowski
$1,500,824
Chief Operating Officer
Alka Chaubey
Chief Medical Officer
$546,149
$759,000
$12,680
$1,317,829
Alka Chaubey
$1,317,829
Chief Medical Officer
Aleksandar Rajkovic
Independent Director
$39,125
$412,054
$0
$451,179
Aleksandar Rajkovic
$451,179
Independent Director
David Barker
Chairman of the Board
$85,000
$164,422
$0
$249,422
David Barker
$249,422
Chairman of the Board
Bionano Genomics Inc listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2022. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us